Patient management by Neoral C2 monitoring: An international consensus statement1, Transplantation, vol.73, issue.Supplement, pp.12-18, 2002. ,
DOI : 10.1097/00007890-200205151-00003
Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference, Therapeutic Drug Monitoring, vol.31, issue.2, pp.139-152, 2009. ,
DOI : 10.1097/FTD.0b013e318198d092
Therapeutic Drug Monitoring for Mycophenolic Acid Is Value for (Little) Money, Clinical Pharmacology & Therapeutics, vol.90, issue.2, pp.203-204, 2011. ,
DOI : 10.1097/TP.0b013e3181d75952
Mycophenolate Mofetil Monitoring: Is There Evidence That It Can Improve Outcomes?, Clinical Pharmacology & Therapeutics, vol.48, issue.2, pp.204-206, 2011. ,
DOI : 10.1056/NEJMoa067411
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation, New England Journal of Medicine, vol.357, issue.25, pp.2562-2575, 2007. ,
DOI : 10.1056/NEJMoa067411
Cyclosporine Sparing with Mycophenolate Mofetil, Daclizumab and Corticosteroids in Renal Allograft Recipients: The CAESAR Study, American Journal of Transplantation, vol.13, issue.3, pp.560-570, 2007. ,
DOI : 10.1097/01.ASN.0000013298.11876.BF
A Time-to-Event Model for Acute Rejections in Paediatric Renal Transplant Recipients Treated with Ciclosporin A. Br, J. Clin. Pharmacol, vol.76, pp.603-615, 2013. ,
Mycophenolate Blood Level Monitoring: Recent Progress, American Journal of Transplantation, vol.14, issue.Suppl, pp.1495-1499, 2009. ,
DOI : 10.1111/j.1600-6143.2009.02678.x
Individualized Mycophenolate Mofetil Dosing Based on Drug Exposure Significantly Improves Patient Outcomes After Renal Transplantation, American Journal of Transplantation, vol.82, issue.1, pp.2496-2503, 2007. ,
DOI : 10.1097/00007691-200412000-00005
Comparing Mycophenolate Mofetil Regimens for de Novo Renal Transplant Recipients: The Fixed-Dose Concentration-Controlled Trial, Transplantation, vol.86, issue.8, pp.1043-51, 2008. ,
DOI : 10.1097/TP.0b013e318186f98a
Early Steroid Withdrawal and Optimization of Mycophenolic Acid Exposure in Kidney Transplant Recipients Receiving Mycophenolate Mofetil, Transplantation, vol.92, issue.11, pp.1244-1251, 2011. ,
DOI : 10.1097/TP.0b013e318234e134
URL : https://hal.archives-ouvertes.fr/hal-01151208
The Impact of Cytomegalovirus Infection and Disease on Rejection Episodes in Renal Allograft Recipients, American Journal of Transplantation, vol.55, issue.9, pp.850-856, 2002. ,
DOI : 10.1034/j.1399-0012.2000.140306.x
Cytomegalovirus-associated renal allograft rejection: new challenges for antiviral preventive strategies, Expert Review of Anti-infective Therapy, vol.8, issue.8, pp.903-910, 2010. ,
DOI : 10.1586/eri.10.63
Effect of Cytomegalovirus Viremia on Subclinical Rejection or Interstitial Fibrosis and Tubular Atrophy in Protocol Biopsy at 3 Months in Renal Allograft Recipients Managed by Preemptive Therapy or Antiviral Prophylaxis, Transplantation, vol.87, issue.3, pp.436-444, 2009. ,
DOI : 10.1097/TP.0b013e318192ded5
Subclinical Viremia Increases Risk for Chronic Allograft Injury in Pediatric Renal Transplantation, Journal of the American Society of Nephrology, vol.21, issue.9, pp.1579-1586, 2010. ,
DOI : 10.1681/ASN.2009111188
CYTOMEGALOVIRUS AS A RISK FACTOR IN RENAL TRANSPLANTATION, Transplantation, vol.30, issue.6, pp.436-439, 1980. ,
DOI : 10.1097/00007890-198012000-00010
A prospective study of rapid methods of detecting cytomegalovirus in the blood of renal transplant recipients in relation to patient and graft survival, Clin.Transplant, vol.10, pp.494-502, 1996. ,
Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival, Kidney International, vol.66, issue.1, pp.329-337, 2004. ,
DOI : 10.1111/j.1523-1755.2004.00735.x
International Survey of Cytomegalovirus Management in Solid Organ Transplantation After the Publication of Consensus Guidelines, Transplantation Journal, vol.95, issue.12, pp.1455-1460, 2013. ,
DOI : 10.1097/TP.0b013e31828ee12e
JM: an R package for the Joint Modeling of Longitudinal and Time-toevent Data, J. Stat. Softw, vol.35, pp.1-33, 2010. ,
Joint modeling of longitudinal and time-to-event data: an overview, Stat. Sin, vol.14, pp.809-834, 2004. ,
Joint longitudinal-survival-cure models and their application to prostate cancer, Stat. Sin, vol.14, pp.835-862, 2004. ,
Mod??lisation conjointe de donn??es longitudinales quantitatives et de d??lais censur??s, Revue d'??pid??miologie et de Sant?? Publique, vol.52, issue.6, pp.502-510, 2004. ,
DOI : 10.1016/S0398-7620(04)99090-6
Prediction of pregnancy: a joint model for longitudinal and binary data, Bayesian Analysis, vol.4, issue.3, pp.523-538, 2009. ,
DOI : 10.1214/09-BA419
Conditional Estimation for Generalized Linear Models When Covariates Are Subject-Specific Parameters in a Mixed Model for Longitudinal Measurements, Biometrics, vol.93, issue.1, pp.1-7, 2004. ,
DOI : 10.1016/S0167-9473(96)00047-3
Joint Models for a Primary Endpoint and Multiple Longitudinal Covariate Processes, Biometrics, vol.50, issue.4, pp.1068-1078, 2007. ,
DOI : 10.1111/j.1541-0420.2007.00822.x
A retrospective analysis of mycophenolic acid and cyclosporin concentrations with acute rejection in renal transplant recipients, Clinical Biochemistry, vol.34, issue.1, pp.77-81, 2001. ,
DOI : 10.1016/S0009-9120(00)00196-X
Therapeutic Drug Monitoring of Mycophenolic Acid in Renal Transplant Recipients, Transplantation Proceedings, vol.37, issue.2, pp.859-860, 2005. ,
DOI : 10.1016/j.transproceed.2004.12.238
The Influence of Mycophenolate Mofetil Versus Azathioprine and Mycophenolic Acid Pharmacokinetics on the Incidence of Acute Rejection and Infectious Complications After Renal Transplantation, Transplantation Proceedings, vol.37, issue.4, pp.1751-1753, 2005. ,
DOI : 10.1016/j.transproceed.2005.03.072
Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant, Journal of Clinical Pharmacy and Therapeutics, vol.47, issue.1, pp.27-34, 2006. ,
DOI : 10.1097/00007691-200102000-00007
The Weight of Pharmacokinetic Parameters for Mycophenolic Acid in Prediction of Rejection Outcome: The Receiver Operating Characteristic Curve Analysis, Transplantation Proceedings, vol.38, issue.1, pp.86-89, 2006. ,
DOI : 10.1016/j.transproceed.2005.11.084
Monitoring of mycophenolic acid in pediatric renal transplant recipients, Transplantation Proceedings, vol.33, issue.1-2, pp.1040-1043, 2001. ,
DOI : 10.1016/S0041-1345(00)02322-8
Impact of longitudinal exposure to mycophenolic acid on acute rejection in renal-transplant recipients using a joint modeling approach, Pharmacological Research, vol.72, pp.52-60, 2013. ,
DOI : 10.1016/j.phrs.2013.03.009
URL : https://hal.archives-ouvertes.fr/inserm-00809389
Time-Varying Belatacept Exposure and Its Relationship to Efficacy/Safety Responses in Kidney-Transplant Recipients, Clinical Pharmacology & Therapeutics, vol.58, issue.2, pp.251-257, 2012. ,
DOI : 10.1038/clpt.2012.84
Tacrolimus trough levels after month 3 as a predictor of acute rejection following kidney transplantation: a lesson learned from DeKAF Genomics, Transplant International, vol.91, issue.10, pp.982-989, 2013. ,
DOI : 10.1111/tri.12155
Fixed- or Controlled-Dose Mycophenolate Mofetil with Standard- or Reduced-Dose Calcineurin Inhibitors: The Opticept Trial, American Journal of Transplantation, vol.27, issue.2 Suppl, pp.1607-1619, 2009. ,
DOI : 10.1111/j.1600-6143.2009.02668.x
Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation, Transplantation Journal, vol.96, issue.4, pp.333-360, 2013. ,
DOI : 10.1097/TP.0b013e31829df29d
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions, American Journal of Transplantation, vol.23, issue.4, pp.753-760, 2008. ,
DOI : 10.1046/j.1523-1755.1999.00299.x
A Fully Automated Turbulent-Flow Liquid Chromatography-Tandem Mass Spectrometry Technique for Monitoring Antidepressants in Human Serum, Therapeutic Drug Monitoring, vol.28, issue.1, pp.123-130, 2006. ,
DOI : 10.1097/01.ftd.0000194026.04483.c3
Tacrolimus Population Pharmacokinetic-Pharmacogenetic Analysis and Bayesian Estimation in Renal Transplant Recipients, Clinical Pharmacokinetics, vol.76, issue.8, pp.805-816, 2009. ,
DOI : 10.2165/11318080-000000000-00000
URL : https://hal.archives-ouvertes.fr/hal-01390737
Maximum A Posteriori Bayesian Estimation of Mycophenolic Acid Pharmacokinetics in Renal Transplant Recipients at Different Postgrafting Periods, Therapeutic Drug Monitoring, vol.27, issue.3, pp.354-361, 2005. ,
DOI : 10.1097/01.ftd.0000162231.90811.38
Perl-speaks-NONMEM (PsN)???a Perl module for NONMEM related programming, Computer Methods and Programs in Biomedicine, vol.75, issue.2, pp.85-94, 2004. ,
DOI : 10.1016/j.cmpb.2003.11.003
Xpose???an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM, Computer Methods and Programs in Biomedicine, vol.58, issue.1 ,
DOI : 10.1016/S0169-2607(98)00067-4
A Time to Event Tutorial for Pharmacometricians, CPT: Pharmacometrics & Systems Pharmacology, vol.43, issue.5, p.43, 2013. ,
DOI : 10.1023/A:1023249510224
Inference for multi-state models from interval-censored data, Statistical Methods in Medical Research, vol.11, issue.2, pp.167-182, 2002. ,
DOI : 10.1191/0962280202sm279ra
Patterns and power for the visual predictive checks [abstract] Available at:http://www.page-meeting, p.1029, 2013. ,
A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models, Computer Methods and Programs in Biomedicine, vol.59, issue.1 ,
DOI : 10.1016/S0169-2607(98)00098-4
PsN-Toolkit???A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM, Computer Methods and Programs in Biomedicine, vol.79, issue.3, pp.241-257, 2005. ,
DOI : 10.1016/j.cmpb.2005.04.005
Time to Event analysis Diagnostic Plots [slights] Available at, p.8, 2013. ,